Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
about
Molecular Aspects of Head and Neck Cancer TherapyOncogenic mutations of PIK3CA in human cancersThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsWhole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiencyA SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA geneClinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinomaPIK3CA mutations in mucinous cystic neoplasms of the pancreas.Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.The molecular pathogenesis of head and neck squamous cell carcinomaDissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.Gene of the month: PIK3CA.Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinomaThe effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC.Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.
P2860
Q28082815-40DF2ED5-F3AA-4530-82B7-E6778D319366Q28284802-6AFDDD70-C086-4EBB-8927-3C730B69A120Q30365726-DBD5076D-6242-44CE-9A0C-9D99E7D8C795Q30465158-AA4489EB-CB7A-4539-BC25-1D8B7766B6B6Q33436440-9EE9310C-A972-4598-9F06-1F25BAEFAD62Q33598317-8EC06F42-0119-483E-98AD-8BF315436037Q33942405-A8155E9F-CD0C-4E91-8F08-D1938B89D910Q34330763-7FD84F8D-A5B7-4798-86C6-778F102949C0Q34497010-DDDCD3EF-544E-4A3F-A3BF-E5C18A5C081EQ35068192-D97C78C5-1DFC-41AC-9C24-44BCA0E8DC55Q35994228-152076F0-4561-4FD1-A894-2702110C4C54Q36659339-4E43601A-64D7-4AF6-AD22-55B742872C9BQ37008823-BD142290-45EC-46D7-BCD1-F68989E9CFAEQ37301942-EA466585-0A4D-491C-8ECC-7210E2536A11Q37558614-DF6C2366-8DBE-4010-A969-2AECA6BABDECQ37589094-EF9A5543-C504-4A9F-A2ED-D11CF9C4329CQ38358055-E169324B-003F-4425-BD9C-71EE28CB71D5Q39097109-2DA4E903-0DEE-4F4A-9D3B-6CA15331AFCBQ41104247-73676BF3-03E0-4D40-AA5F-38B28CE79BB5Q41134525-D108B2D9-21DF-43F6-99E7-7ED3AE6FB0C6Q41667207-D766D121-E266-4B12-B5A0-C82D30E0EA46Q41906992-81D33B04-7E35-4D89-AA74-7A157155EEBEQ50440575-D0486B99-314D-4368-8228-1564D2C5E005Q53206186-09D64D5D-DB7A-47EA-8BC9-85F5E8745F8DQ54389429-2A8370B7-9E3E-442C-BC30-44588B5CE693
P2860
Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@en
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@nl
type
label
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@en
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@nl
prefLabel
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@en
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@nl
P2093
P2860
P356
P1476
Novel mutant-enriched sequenci ...... utations in pharyngeal cancer.
@en
P2093
Adel M Assaad
Gloria H Su
Guo-Xia Tong
Lanny G Close
Spiros Manolidis
Wanglong Qiu
P2860
P304
P356
10.1002/IJC.23217
P577
2008-03-01T00:00:00Z